Braxia Scientific Corp (BRAXF)
0.0024
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Braxia Scientific Enterprise Value: 0.6788M for Sept. 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 27, 2024 | 0.6788M |
| September 26, 2024 | 0.5513M |
| September 25, 2024 | 0.4947M |
| September 24, 2024 | 0.608M |
| September 23, 2024 | 0.6929M |
| September 20, 2024 | 0.6363M |
| September 19, 2024 | 0.6363M |
| September 18, 2024 | 0.6363M |
| September 17, 2024 | 0.9479M |
| September 16, 2024 | 0.6391M |
| September 13, 2024 | 0.7921M |
| September 12, 2024 | 0.8346M |
| September 11, 2024 | 0.7213M |
| September 10, 2024 | 0.8346M |
| September 09, 2024 | 0.8771M |
| September 06, 2024 | 0.8091M |
| September 05, 2024 | 0.7213M |
| September 04, 2024 | 0.7071M |
| September 03, 2024 | 0.8374M |
| August 30, 2024 | 0.5513M |
| August 29, 2024 | 0.5513M |
| August 28, 2024 | 0.6646M |
| August 27, 2024 | 0.5513M |
| August 26, 2024 | 0.6646M |
| August 23, 2024 | 0.7779M |
| Date | Value |
|---|---|
| August 22, 2024 | 0.7156M |
| August 21, 2024 | 0.608M |
| August 20, 2024 | 0.5796M |
| August 19, 2024 | 0.5513M |
| August 16, 2024 | 0.6929M |
| August 15, 2024 | 0.5796M |
| August 14, 2024 | 0.608M |
| August 13, 2024 | 0.438M |
| August 12, 2024 | 0.4097M |
| August 09, 2024 | 0.438M |
| August 08, 2024 | 0.5796M |
| August 07, 2024 | 0.5513M |
| August 06, 2024 | 0.608M |
| August 05, 2024 | 0.608M |
| August 02, 2024 | 0.4663M |
| August 01, 2024 | 0.438M |
| July 31, 2024 | 0.5513M |
| July 30, 2024 | 0.4097M |
| July 29, 2024 | 0.4663M |
| July 26, 2024 | 0.7213M |
| July 25, 2024 | 0.8204M |
| July 24, 2024 | 0.9196M |
| July 23, 2024 | 0.6929M |
| July 22, 2024 | 1.013M |
| July 19, 2024 | 0.9621M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.2428M
Minimum
Mar 11 2022
157.32M
Maximum
Dec 14 2020
23.37M
Average
4.202M
Median
Jan 10 2023
Enterprise Value Benchmarks
| Acasti Pharma Inc | 12.23M |
| Aurinia Pharmaceuticals Inc | 710.50M |
| Edesa Biotech Inc | 11.89M |
| Lexaria Bioscience Corp | 38.87M |
| Xenon Pharmaceuticals Inc | 2.207B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.6663M |
| Revenue (Quarterly) | 0.3617M |
| Total Expenses (Quarterly) | 0.9914M |
| EPS Diluted (Quarterly) | -0.0025 |
| Gross Profit Margin (Quarterly) | 16.65% |
| Profit Margin (Quarterly) | -184.2% |
| Earnings Yield | -1.44K% |
| Normalized Earnings Yield | -771.59 |